Harnessing nanoprodrugs to enhance cancer immunotherapy: overcoming barriers to precision treatment
Nanoprodrugs, leveraging advanced nanoparticle-based delivery systems, represent a promising strategy to enhance the efficacy of immunotherapy in cancer treatment. These systems offer precise tumor targeting, controlled drug release, and the potential to modulate the immune microenvironment, address...
Saved in:
| Main Authors: | Yunfan Lin, Pei Lin, Xu Chen, Xinyuan Zhao, Li Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425005034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ultrasound-activated carrier-free nanoprodrugs enhanced universality and efficiency of solid tumor-targeting chemotherapy
by: Xiaodan Xu, et al.
Published: (2025-08-01) -
Hypoxia-responsive core-cross-linked supramolecular nanoprodrug based on dendritic drug-drug conjugates for synergetic anticancer therapy
by: Yue Ding, et al.
Published: (2025-04-01) -
Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistance
by: Jian Song, et al.
Published: (2025-06-01) -
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
by: Zexing Shan, et al.
Published: (2024-07-01) -
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy
by: Jinhe Zhang, et al.
Published: (2025-08-01)